Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

RecruitingOBSERVATIONAL
Enrollment

933

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

August 1, 2026

Conditions
Colorectal CancerSolid Tumor
Interventions
DRUG

Irinotecan Liposome

The experimental group will collect data from patients treated with Nal-IRI as the chemotherapy regimen. It is recommended to use according to the label, clinical practice shall prevail.

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University

OTHER